Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-25

Clinical Trial Update: Cohort Study of Risk Reducing Salpingectomy [NA]

View source ↗

Summary

This document provides an update on a completed cohort study evaluating risk-reducing salpingectomy as a strategy to lower ovarian cancer risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Sterilization, Tubal, Salpingectomy | NA | Status: COMPLETED